PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...
Many promising peptides fail because they degrade too easily. This limits their usefulness in drug design and creates ...
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of three service offerings ...
FUJISAWA, Japan--(BUSINESS WIRE)--SynCrest Inc., a peptide and nucleotide CRDMO (Contract Research, Development and Manufacturing Organization) joint venture between Otsuka Chemical Co., Ltd. and ...
A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more stable and drug-like peptides, opening the door to medicines that could target ...
KAWASAKI, Japan--(BUSINESS WIRE)--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo:4587) today announced its ...
The use of monoclonal antibodies has changed the treatment of several immune-mediated inflammatory diseases, including psoriasis. However, these large proteins must be administered by injection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback